Salud financiera de hoja de balance de Wellell

Salud financiera controles de criterios 6/6

Wellell tiene un patrimonio de accionistas total de NT$2.3B y una deuda total de NT$320.7M, lo que sitúa su ratio deuda-patrimonio en 13.7%. Sus activos y pasivos totales son NT$3.2B y NT$884.0M respectivamente. El BAIT de Wellell es de NT$194.2M, por lo que su ratio de cobertura de intereses es de 24.4. Tiene efectivo e inversiones a corto plazo que ascienden a NT$759.3M.

Información clave

13.7%

Ratio deuda-patrimonio

NT$320.71m

Deuda

Ratio de cobertura de intereses	24.4x
Efectivo	NT$759.31m
Patrimonio	NT$2.34b
Total pasivo	NT$883.98m
Activos totales	NT$3.22b

Actualizaciones recientes sobre salud financiera

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Recent updates

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Mar 23

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Mar 29

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Mar 01

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Feb 11

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Jan 27

Is Apex Medical (TPE:4106) Using Too Much Debt?

Jan 12

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Dec 28

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

Dec 13

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Nov 27

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (NT$1.7B) de 4106 superan a sus pasivos a corto plazo (NT$698.9M).

Pasivo a largo plazo: Los activos a corto plazo de 4106 (NT$1.7B) superan a sus pasivos a largo plazo (NT$185.1M).

Historial y análisis de deuda-patrimonio

Nivel de deuda: 4106 tiene más efectivo que su deuda total.

Reducción de la deuda: El ratio deuda-patrimonio de 4106 ha pasado de 34.4% a 13.7% en los últimos 5 años.

Cobertura de la deuda: La deuda de 4106 está bien cubierta por el flujo de caja operativo (142.1%).

Cobertura de intereses: Los pagos de intereses de la deuda de 4106 están bien cubiertos por el BAIT (24.4x cobertura).

Salud financiera de hoja de balance de Wellell

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Apex Medical (TPE:4106) Using Too Much Debt?

Recent updates

Some May Be Optimistic About Wellell's (TWSE:4106) Earnings

Wellell Inc. Appoints Su Ya-Ling as Chief Operating Officer

Full year 2023 earnings released: EPS: NT$1.51 (vs NT$1.60 in FY 2022)

Wellell Inc., Annual General Meeting, Jun 24, 2024

Wellell Inc. Appoints Lee Pi Kai as Chief Strategy Officer

Wellell Inc. Announces Resignation of Tan, Jian-Qiang as Chief Operating Officer

Second quarter 2023 earnings released: EPS: NT$0.50 (vs NT$0.51 in 2Q 2022)

Upcoming dividend of NT$0.85 per share at 2.7% yield

New minor risk - Dividend sustainability

Investor sentiment improves as stock rises 16%

Wellell Inc. Appoints Shin-Ho,Chen as Corporate Governance Officer

Full year 2022 earnings released: EPS: NT$1.60 (vs NT$1.01 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: NT$0.59 (vs NT$0.31 in 3Q 2021)

Insufficient new directors

Wellell Inc. Announces Change Member of Remuneration Committee

Second quarter 2022 earnings released: EPS: NT$0.51 (vs NT$0.34 in 2Q 2021)

Insufficient new directors

Apex Medical Corp. Approves Cash Dividend for the Year 2021

Apex Medical Corp. Announces Change of Alan Chang as Research and Development Officer, Effective May 31, 2022

Apex (Kunshan)Medical Corp. to Announce Production Can Be Resume Gradually

Apex Medical Corp. Announces On Behalf of the Subsidiaries Apex (Kunshan) Medical Corp. and Wellell (Kunshan) Co., Ltd. Extend Temporary Suspension of Production

Wellell (Kunshan) Co., Ltd. Announces the Temporary Suspension of Production

Full year 2021 earnings released: EPS: NT$1.01 (vs NT$1.04 in FY 2020)

Wellell Inc., Annual General Meeting, Jun 20, 2022

Third quarter 2021 earnings released: EPS NT$0.31 (vs NT$0.28 in 3Q 2020)

High number of new directors

High number of new directors

High number of new directors

Upcoming dividend of NT$0.55 per share

Second quarter 2021 earnings released: EPS NT$0.34 (vs NT$0.55 in 2Q 2020)

High number of new directors

High number of new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS NT$0.29 (vs NT$0.074 in 1Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS NT$1.04 (vs NT$0.87 in FY 2019)

Should You Or Shouldn't You: A Dividend Analysis on Apex Medical Corp. (TPE:4106)

Reflecting on Apex Medical's (TPE:4106) Share Price Returns Over The Last Five Years

Apex Medical Corp. Announces Executive Changes, Effective March 01, 2021

Returns On Capital At Apex Medical (TPE:4106) Paint An Interesting Picture

Apex Medical Corp. Appoints Alan Chang as Director of R&D

New 90-day low: NT$25.65

Weak Financial Prospects Seem To Be Dragging Down Apex Medical Corp. (TPE:4106) Stock

Is Apex Medical (TPE:4106) Using Too Much Debt?

New 90-day low: NT$28.00

Is Apex Medical Corp. (TPE:4106) A Good Fit For Your Dividend Portfolio?

Does Apex Medical's (TPE:4106) Statutory Profit Adequately Reflect Its Underlying Profit?

New 90-day low: NT$28.90

Apex Medical (TPE:4106) Share Prices Have Dropped 28% In The Last Five Years

Third quarter 2020 earnings released: EPS NT$0.28

New 90-day low: NT$31.05

First half earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Descubre empresas con salud financiera